SG11201503410VA - Solid form of dihydro-pyrido-oxazine derivative - Google Patents
Solid form of dihydro-pyrido-oxazine derivativeInfo
- Publication number
- SG11201503410VA SG11201503410VA SG11201503410VA SG11201503410VA SG11201503410VA SG 11201503410V A SG11201503410V A SG 11201503410VA SG 11201503410V A SG11201503410V A SG 11201503410VA SG 11201503410V A SG11201503410V A SG 11201503410VA SG 11201503410V A SG11201503410V A SG 11201503410VA
- Authority
- SG
- Singapore
- Prior art keywords
- pyrido
- dihydro
- solid form
- oxazine derivative
- oxazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GC201222895 | 2012-11-26 | ||
| IR1391307213 | 2012-12-04 | ||
| PCT/IB2013/060412 WO2014102630A1 (en) | 2012-11-26 | 2013-11-26 | Solid form of dihydro-pyrido-oxazine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201503410VA true SG11201503410VA (en) | 2015-05-28 |
Family
ID=51019963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201503410VA SG11201503410VA (en) | 2012-11-26 | 2013-11-26 | Solid form of dihydro-pyrido-oxazine derivative |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP2928896B1 (en) |
| KR (1) | KR102184069B1 (en) |
| CN (1) | CN104870451B (en) |
| AU (1) | AU2013368997B8 (en) |
| BR (1) | BR112015009870A2 (en) |
| CA (1) | CA2891521A1 (en) |
| CL (1) | CL2015001409A1 (en) |
| CY (1) | CY1119702T1 (en) |
| DK (1) | DK2928896T3 (en) |
| GT (1) | GT201500124A (en) |
| HK (1) | HK1209419A1 (en) |
| IL (1) | IL238889B (en) |
| MX (1) | MX366342B (en) |
| NZ (1) | NZ706865A (en) |
| PE (1) | PE20150946A1 (en) |
| PH (1) | PH12015501052A1 (en) |
| PL (1) | PL2928896T3 (en) |
| PT (1) | PT2928896T (en) |
| SG (1) | SG11201503410VA (en) |
| TN (1) | TN2015000128A1 (en) |
| TW (1) | TW201422625A (en) |
| WO (1) | WO2014102630A1 (en) |
| ZA (1) | ZA201502350B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY170922A (en) | 2011-12-22 | 2019-09-18 | Novartis Ag | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives |
| AU2019322538B2 (en) | 2018-08-13 | 2021-09-30 | F. Hoffmann-La Roche Ag | New heterocyclic compounds as monoacylglycerol lipase inhibitors |
| BR112022002375A2 (en) | 2019-09-12 | 2022-07-19 | Hoffmann La Roche | 4,4A,5,7,8,8A-HEXAPYRIDO[4,3-B][1,4]OXAZIN-3-ONA COMPOUNDS AS MAGL INHIBITORS |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU11248A1 (en) | 1927-03-29 | 1929-09-30 | В.С. Григорьев | Anthracene cleaning method |
| GB1524747A (en) | 1976-05-11 | 1978-09-13 | Ici Ltd | Polypeptide |
| DE3372965D1 (en) | 1982-07-23 | 1987-09-17 | Ici Plc | Amide derivatives |
| GB8327256D0 (en) | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
| US5093330A (en) | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
| US5010099A (en) | 1989-08-11 | 1991-04-23 | Harbor Branch Oceanographic Institution, Inc. | Discodermolide compounds, compositions containing same and method of preparation and use |
| NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
| GB9300059D0 (en) | 1992-01-20 | 1993-03-03 | Zeneca Ltd | Quinazoline derivatives |
| TW225528B (en) | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
| GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
| EP0817775B1 (en) | 1995-03-30 | 2001-09-12 | Pfizer Inc. | Quinazoline derivatives |
| GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
| US5843901A (en) | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
| KR100437582B1 (en) | 1995-07-06 | 2004-12-17 | 노파르티스 아게 | Pyrrolopyrimidines and Processes for the Preparation Thereof |
| US5760041A (en) | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
| GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| DK0892789T4 (en) | 1996-04-12 | 2010-04-06 | Warner Lambert Co | Irreversible inhibitors of tyrosine kinases |
| WO1997049688A1 (en) | 1996-06-24 | 1997-12-31 | Pfizer Inc. | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases |
| EP0923583A1 (en) | 1996-08-30 | 1999-06-23 | Novartis AG | Method for producing epothilones, and intermediate products obtained during the production process |
| WO1998010121A1 (en) | 1996-09-06 | 1998-03-12 | Obducat Ab | Method for anisotropic etching of structures in conducting materials |
| WO1998010767A2 (en) | 1996-09-13 | 1998-03-19 | Sugen, Inc. | Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
| EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
| DE59712968D1 (en) | 1996-11-18 | 2008-10-30 | Biotechnolog Forschung Gmbh | Epothilones E and F |
| US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
| CO4940418A1 (en) | 1997-07-18 | 2000-07-24 | Novartis Ag | MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL-2-PIRIMIDINAMINE, PROCESSES FOR ITS MANUFACTURE AND USE |
| GB9721069D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Polymeric derivatives of camptothecin |
| US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
| DE69927790T2 (en) | 1998-02-25 | 2006-07-20 | Sloan-Kettering Institute For Cancer Research | SYNTHESIS OF EPOTHILONES, ITS INTERMEDIATE PRODUCTS AND ANALOGICAL COMPOUNDS |
| AU5620299A (en) | 1998-08-11 | 2000-03-06 | Novartis Ag | Isoquinoline derivatives with angiogenesis inhibiting activity |
| AU768220B2 (en) | 1998-11-20 | 2003-12-04 | Kosan Biosciences, Inc. | Recombinant methods and materials for producing epothilone and epothilone derivatives |
| PE20020354A1 (en) | 2000-09-01 | 2002-06-12 | Novartis Ag | HYDROXAMATE COMPOUNDS AS HISTONE-DESACETILASE (HDA) INHIBITORS |
| KR100916613B1 (en) | 2000-11-07 | 2009-09-14 | 노파르티스 아게 | Indolylmaleimide derivatives as protein kinase C inhibitors |
| AR035885A1 (en) | 2001-05-14 | 2004-07-21 | Novartis Ag | DERIVATIVES OF 4-AMINO-5-FENIL-7-CYCLLOBUTILPIRROLO (2,3-D) PYRIMIDINE, A PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND THE USE OF SUCH DERIVATIVES FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION |
| GB0119249D0 (en) | 2001-08-07 | 2001-10-03 | Novartis Ag | Organic compounds |
| AR039209A1 (en) | 2002-04-03 | 2005-02-09 | Novartis Ag | INDOLILMALEIMIDA DERIVATIVES |
| NZ540427A (en) | 2002-12-09 | 2008-04-30 | Univ Texas | Methods for selectively inhibiting janus tyrosine kinase 3 (Jak3) |
| KR101164541B1 (en) | 2004-01-12 | 2012-07-10 | 와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 | Selective kinase inhibitors |
| GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
| CN101300047A (en) * | 2005-09-07 | 2008-11-05 | 雪兰诺实验室有限公司 | PI3K inhibitors for the treatment of endometriosis |
| GB0620059D0 (en) * | 2006-10-10 | 2006-11-22 | Ucb Sa | Therapeutic agents |
| MY170922A (en) * | 2011-12-22 | 2019-09-18 | Novartis Ag | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives |
-
2013
- 2013-11-25 TW TW102142869A patent/TW201422625A/en unknown
- 2013-11-26 PT PT138241773T patent/PT2928896T/en unknown
- 2013-11-26 CA CA2891521A patent/CA2891521A1/en not_active Abandoned
- 2013-11-26 PL PL13824177T patent/PL2928896T3/en unknown
- 2013-11-26 SG SG11201503410VA patent/SG11201503410VA/en unknown
- 2013-11-26 MX MX2015006650A patent/MX366342B/en active IP Right Grant
- 2013-11-26 NZ NZ706865A patent/NZ706865A/en not_active IP Right Cessation
- 2013-11-26 PE PE2015000687A patent/PE20150946A1/en not_active Application Discontinuation
- 2013-11-26 EP EP13824177.3A patent/EP2928896B1/en active Active
- 2013-11-26 DK DK13824177.3T patent/DK2928896T3/en active
- 2013-11-26 WO PCT/IB2013/060412 patent/WO2014102630A1/en active Application Filing
- 2013-11-26 KR KR1020157013235A patent/KR102184069B1/en active IP Right Grant
- 2013-11-26 AU AU2013368997A patent/AU2013368997B8/en not_active Ceased
- 2013-11-26 BR BR112015009870A patent/BR112015009870A2/en not_active Application Discontinuation
- 2013-11-26 CN CN201380061193.5A patent/CN104870451B/en active Active
-
2015
- 2015-04-02 TN TNP2015000128A patent/TN2015000128A1/en unknown
- 2015-04-08 ZA ZA2015/02350A patent/ZA201502350B/en unknown
- 2015-05-12 PH PH12015501052A patent/PH12015501052A1/en unknown
- 2015-05-18 IL IL238889A patent/IL238889B/en active IP Right Grant
- 2015-05-25 CL CL2015001409A patent/CL2015001409A1/en unknown
- 2015-05-26 GT GT201500124A patent/GT201500124A/en unknown
- 2015-10-14 HK HK15110054.5A patent/HK1209419A1/en not_active IP Right Cessation
-
2017
- 2017-10-13 CY CY20171101078T patent/CY1119702T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104870451B (en) | 2017-07-07 |
| MX2015006650A (en) | 2015-08-10 |
| KR102184069B1 (en) | 2020-11-30 |
| BR112015009870A2 (en) | 2017-12-05 |
| IL238889B (en) | 2021-03-25 |
| EP2928896B1 (en) | 2017-07-19 |
| IL238889A0 (en) | 2015-07-30 |
| PE20150946A1 (en) | 2015-06-28 |
| ZA201502350B (en) | 2017-08-30 |
| HK1209419A1 (en) | 2016-04-01 |
| TW201422625A (en) | 2014-06-16 |
| PT2928896T (en) | 2017-10-25 |
| MX366342B (en) | 2019-07-05 |
| TN2015000128A1 (en) | 2016-10-03 |
| NZ706865A (en) | 2016-04-29 |
| PL2928896T3 (en) | 2018-01-31 |
| WO2014102630A1 (en) | 2014-07-03 |
| DK2928896T3 (en) | 2017-11-06 |
| CL2015001409A1 (en) | 2015-07-24 |
| CA2891521A1 (en) | 2014-07-03 |
| AU2013368997B2 (en) | 2015-09-24 |
| PH12015501052A1 (en) | 2015-07-27 |
| EP2928896A1 (en) | 2015-10-14 |
| GT201500124A (en) | 2016-03-01 |
| AU2013368997A8 (en) | 2015-10-08 |
| CY1119702T1 (en) | 2018-06-27 |
| AU2013368997A1 (en) | 2015-04-30 |
| CN104870451A (en) | 2015-08-26 |
| AU2013368997B8 (en) | 2015-10-08 |
| KR20150091047A (en) | 2015-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1212701A1 (en) | Formulations of enzalutamide | |
| HK1207375A1 (en) | Piperidinylpyrazolopyridine derivative | |
| HK1207363A1 (en) | Novel indanesulfamide derivative | |
| EP2917314A4 (en) | Composition of oligomerate | |
| EP2800747A4 (en) | Polymorphs of perampanel | |
| IL236312A0 (en) | Preparation of 18f-fluciclovine | |
| EP2881113A4 (en) | New application of pogostone | |
| HK1200824A1 (en) | Substituted phenylazole derivative | |
| EP2892529A4 (en) | Uses of (-)-perhexiline | |
| PT2873660T (en) | Indolecarboxamide derivative | |
| PL2807172T3 (en) | Pyrimidooxazocine derivatives as mtor-inhibitors | |
| ZA201502350B (en) | Solid form of hihydro-pyrido-oxazine derivative | |
| EP2842958A4 (en) | Naphthobisthiadiazole derivative | |
| HK1204621A1 (en) | 4-alkanoylamino-3-pyrazolone derivative 4--3- | |
| LT2928896T (en) | Solid form of dihydro-pyrido-oxazine derivative | |
| IL233446A0 (en) | Polymorphs of perampanel | |
| TWM433525U (en) | Structure of calorifier |